Allogene Therapeutics, Inc.
ALLO
$1.21
-$0.01-0.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -50.94M | -59.73M | -59.94M | -66.29M | -66.36M |
| Total Depreciation and Amortization | 3.11M | 3.10M | 3.23M | 3.21M | 3.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.04M | 12.00M | 14.74M | 27.85M | 17.51M |
| Change in Net Operating Assets | -2.24M | -8.29M | 5.27M | -8.88M | -18.39M |
| Cash from Operations | -39.03M | -52.93M | -36.70M | -44.12M | -63.59M |
| Capital Expenditure | -44.00K | -99.00K | -257.00K | -429.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.88M | 6.28M | 55.19M | -75.56M | 74.61M |
| Cash from Investing | 43.84M | 6.18M | 54.93M | -75.99M | 74.61M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.51M | 10.64M | 5.74M | 679.00K | 106.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.56M | 3.35M | 0.00 | 0.00 | 2.28M |
| Cash from Financing | 5.07M | 13.99M | 5.74M | 679.00K | 108.60M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.88M | -32.76M | 23.98M | -119.43M | 119.63M |